losartan has been researched along with Apolipoprotein B-100, Familial Defective in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan (50 mg/day) was given to a patient with coronary heart disease who had been treated by DSC-LDL apheresis and had experienced an anaphylactoid reaction by administration of an angiotensin converting enzyme inhibitor." | 1.30 | Effects of losartan on low-density lipoprotein apheresis. ( Kojima, S; Kuramochi, M; Saotome, M; Shida, M; Tanaka, K; Yoshitomi, Y, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pintus, S | 1 |
| Pintus, P | 1 |
| Maxia, P | 1 |
| Anedda, S | 1 |
| Kojima, S | 1 |
| Yoshitomi, Y | 1 |
| Saotome, M | 1 |
| Tanaka, K | 1 |
| Shida, M | 1 |
| Kuramochi, M | 1 |
2 other studies available for losartan and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Use of losartan in FH patients during treatment with DSC-LDL apheresis.
Topics: Angiotensin II; Blood Component Removal; Dextran Sulfate; Humans; Hyperlipoproteinemia Type II; Hypo | 1997 |
Effects of losartan on low-density lipoprotein apheresis.
Topics: Aldosterone; Antihypertensive Agents; Bradykinin; Combined Modality Therapy; Follow-Up Studies; Huma | 1999 |